Svastia
500 GlobalSan Francisco, GB · Founded 2019 · 1 employees on LinkedIn · 1 known investors
Svastia is a clinical-genomic platform that uses genetic screening to improve cancer therapy outcomes for pharmaceutical companies and hospitals. The platform bundles contract research services with bioinformatics analysis, and coordinates a distributed network of laboratory service providers to support drug development, clinical trial patient selection, and personalized treatment recommendations.
Founders & leadership
Svastia was founded in 2019 by Balamurali Rathinam and Parthiban Vijayarangakannan.
BR
Balamurali Rathinam
PV
Parthiban Vijayarangakannan
Investors · 1
Frequently asked questions
- What does Svastia do?
- Svastia is a clinical-genomic platform that uses genetic screening to improve cancer therapy outcomes for pharmaceutical companies and hospitals. The platform bundles contract research services with bioinformatics analysis, and coordinates a distributed network of laboratory service providers to support drug development, clinical trial patient selection, and personalized treatment recommendations.
- Who founded Svastia?
- Svastia was founded by Balamurali Rathinam, Parthiban Vijayarangakannan in 2019.
- Who are Svastia's investors?
- Svastia's investors include 500 Global.
- Where is Svastia headquartered?
- Svastia is headquartered in San Francisco, GB.